Christoph Rader, Ph.D.
Affiliations: | 2012 | Scripps Research Institute | |
| 2003-2012 | Experimental Transplantation and Immunology Branch | NCI, Somers, CT, United States |
Google:
"Christoph Rader"Mean distance: 16.43 (cluster 11) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Peter Sonderegger | grad student | 1991-1995 | Universität Zürich |
| Carlos F. Barbas, III | post-doc | 1996-1999 | Scripps Institute (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stepanov AV, Xie J, Zhu Q, et al. (2023) Control of the antitumour activity and specificity of CAR T cells via organic adapters covalently tethering the CAR to tumour cells. Nature Biomedical Engineering |
| Chang J, Rader C, Peng H. (2023) A mammalian cell display platform based on scFab transposition. Antibody Therapeutics. 6: 157-169 |
| Cyr MG, Wilson HD, Spierling AL, et al. (2023) Concerted antibody and antigen discovery by differential whole-cell phage display selections and multi-omic target deconvolution. Journal of Molecular Biology. 168085 |
| Steele AD, Kiefer AF, Hwang D, et al. (2023) Application of a Biocatalytic Strategy for the Preparation of Tiancimycin-Based Antibody-Drug Conjugates Revealing Key Insights into Structure-Activity Relationships. Journal of Medicinal Chemistry |
| Cyr MG, Mhibik M, Qi J, et al. (2022) Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia. Journal For Immunotherapy of Cancer. 10 |
| Hwang D, Nilchan N, Park H, et al. (2022) Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation. Bioconjugate Chemistry |
| Hu EY, Do P, Goswami S, et al. (2021) The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia. Blood Advances. 5: 3152-3162 |
| Lin CW, Zheng T, Grande G, et al. (2021) A new immunochemical strategy for triple-negative breast cancer therapy. Scientific Reports. 11: 14875 |
| Goydel RS, Rader C. (2021) Antibody-based cancer therapy. Oncogene. 40: 3655-3664 |
| Nilchan N, Alburger JM, Roush WR, et al. (2021) An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation. Biochemistry |